Related Experiment Video
Updated: Aug 23, 2025

Neutrophil Lifespan Extension with CLON-G and an In Vitro Spontaneous Death Assay
Published on: May 12, 2023
Aminoglycosides' dosage in hematological malignancies and febrile neutropenia: extended interval or conventional
Cabrera Figueroa Se1,2, Vásquez Remolcoy Da1,2, Cisterna Castillo Pa3
1Personalized Therapy Unit, Regional Clinical Dr Guillermo Grant Benavente Hospital, San Martín, 1436, Concepción, Chile.
Abstract:
A patient with acute myeloid leukemia presented various episodes of febrile neutropenia, for which there was no positive response to antibiotic treatments. Following an episode of bacteremia by extensively drug-resistant Klebsiella pneumoniae, amikacin was prescribed, pharmacokinetic analyses of its plasma concentrations were performed and the dosage interval was narrowed to 12 and 8 h in order to counteract the reduced postantibiotic effect due to the patient being immunocompromised. The patient responded positively, with procalcitonin decreasing and body temperature normalizing. Recovery was finally achieved, without renal or auditory damage. This case proposes tightening dosage intervals for aminoglycosides as an effective strategy in immunocompromised patients. Aminoglycosides are given over extended intervals (24 h), considering concentration-dependent effectiveness, nephrotoxicity and postantibiotic effect. Leukocytes appear to play a determining role in the postantibiotic effect, with no proposed dosing strategy for strongly immunocompromised patients.
Insights
Shortening aminoglycoside dosing intervals may improve treatment outcomes for immunocompromised patients with infections. This strategy was effective in a patient with acute myeloid leukemia and extensively drug-resistant bacteria, avoiding toxicity.
Area of Science:
- Infectious Diseases
- Pharmacology
- Hematology
Background:
- Febrile neutropenia is a common complication in acute myeloid leukemia patients.
- Extensively drug-resistant bacteria pose a significant treatment challenge, especially in immunocompromised individuals.
- Standard aminoglycoside dosing may be less effective in immunocompromised patients due to a reduced postantibiotic effect.
Purpose of the Study:
- To evaluate the efficacy and safety of a modified aminoglycoside dosing strategy in an immunocompromised patient.
- To investigate the impact of narrowed aminoglycoside dosage intervals on treatment outcomes in a patient with extensively drug-resistant bacteremia.
Main Methods:
- A case report of a patient with acute myeloid leukemia and febrile neutropenia.
- Pharmacokinetic analysis of amikacin plasma concentrations.
- Dosage interval adjustment of amikacin from extended to 12 and 8-hour intervals.
- Monitoring of clinical response, procalcitonin levels, and signs of toxicity.
Main Results:
- The patient achieved a positive clinical response with normalization of body temperature and decreased procalcitonin levels.
- Successful eradication of extensively drug-resistant Klebsiella pneumoniae bacteremia.
- No evidence of nephrotoxicity or ototoxicity was observed during treatment.
Conclusions:
- Narrowing the dosage interval of aminoglycosides may be an effective strategy for treating infections in immunocompromised patients.
- This modified dosing approach can enhance the postantibiotic effect, leading to improved treatment outcomes.
- Further studies are warranted to validate this dosing strategy in larger immunocompromised patient populations.
More Related Videos
06:19Author Spotlight: Characterizing Airway Environments to Advance Model Systems and Antimicrobial Discovery in Cystic Fibrosis and Chronic Respiratory Infections
Published on: October 11, 2024
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
Related Concept Videos
Rational Dosage Regimen: Maintenance Dose and Loading Dose
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Dosage Regimen: Fixed Dose
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Acute Pyelonephritis II: Diagnostic Studies and Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention